Similarly, overexpression of Bcl-2 and Bcl-XL in NB cell lines was described to block chemotherapy-induced apoptosis, thus suggesting that the expression of these proteins may promote the drug resistance characteristic of high-risk NBs (Dole et al, 1994, 1995). This evidence concerns the gene BCL2L1 and neuroblastoma.